Education
About Us
Working with TipRanks
Follow Us
IPCA Laboratories Limited (IN:IPCALAB)
:IPCALAB
IPCALAB Stock Chart & Stats
₹1441.45
-₹42.20(-2.43%)
At close: 4:00 PM EST
₹1441.45
-₹42.20(-2.43%)
Day’s Range― - ―
52-Week Range₹1,200.00 - ₹1,757.65
Previous CloseN/A
Volume578.66K
Average Volume (3M)6.78K
Market Cap
₹362.90B
Enterprise Value₹397.84B
Total Cash (Recent Filing)₹11.05B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)43.6
Beta0.68
Next Earnings
Feb 18, 2026EPS Estimate
9.1Next Dividend Ex-DateN/A
Dividend Yield0.28%
Share Statistics
EPS (TTM)13.10
Shares Outstanding253,659,230
10 Day Avg. Volume6,645
30 Day Avg. Volume6,776
Financial Highlights & Ratios
PEG Ratio1.37
Price to Book (P/B)5.08
Price to Sales (P/S)3.95
P/FCF Ratio70.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IPCA Laboratories Limited News
IPCALAB FAQ
What was IPCA Laboratories Limited’s price range in the past 12 months?
IPCA Laboratories Limited lowest stock price was ₹1200.00 and its highest was ₹1757.65 in the past 12 months.
What is IPCA Laboratories Limited’s market cap?
IPCA Laboratories Limited’s market cap is ₹362.90B.
When is IPCA Laboratories Limited’s upcoming earnings report date?
IPCA Laboratories Limited’s upcoming earnings report date is Feb 18, 2026 which is in 62 days.
How were IPCA Laboratories Limited’s earnings last quarter?
IPCA Laboratories Limited released its earnings results on Nov 13, 2025. The company reported ₹13.1 earnings per share for the quarter, beating the consensus estimate of ₹10.72 by ₹2.38.
Is IPCA Laboratories Limited overvalued?
According to Wall Street analysts IPCA Laboratories Limited’s price is currently Overvalued.
Does IPCA Laboratories Limited pay dividends?
IPCA Laboratories Limited pays a Semiannually dividend of ₹2 which represents an annual dividend yield of 0.28%. See more information on IPCA Laboratories Limited dividends here
What is IPCA Laboratories Limited’s EPS estimate?
IPCA Laboratories Limited’s EPS estimate is 9.1.
How many shares outstanding does IPCA Laboratories Limited have?
IPCA Laboratories Limited has 253,659,230 shares outstanding.
What happened to IPCA Laboratories Limited’s price movement after its last earnings report?
IPCA Laboratories Limited reported an EPS of ₹13.1 in its last earnings report, beating expectations of ₹10.72. Following the earnings report the stock price went down -2.921%.
Which hedge fund is a major shareholder of IPCA Laboratories Limited?
Currently, no hedge funds are holding shares in IN:IPCALAB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IPCA Laboratories Limited
IPCA Laboratories Limited (IPCALAB) is a leading Indian pharmaceutical company engaged in the development, manufacturing, and marketing of a wide range of pharmaceutical formulations and active pharmaceutical ingredients (APIs). Established in 1949, the company operates across various sectors, including cardiology, diabetes, psychiatry, neurology, and anti-infectives, among others. IPCALAB offers a diverse portfolio of products, including generic medications, branded formulations, and over-the-counter (OTC) drugs, catering to both domestic and international markets.
Technical Analysis
Ajanta Pharma Limited
―
Biocon Limited
―
Gland Pharma Ltd.
―
Glenmark Pharmaceuticals Limited
―
Laurus Labs Ltd.
―